Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Non-Current Assets (2016 - 2020)

Historic Other Non-Current Assets for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $1.3 million.

  • Larimar Therapeutics' Other Non-Current Assets changed 0.0% to $1.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $90000.0 for FY2019, which is 5789.47% up from last year.
  • Larimar Therapeutics' Other Non-Current Assets amounted to $1.3 million in Q3 2020, which was down 0.0% from $1.3 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Other Non-Current Assets registered a high of $1.3 million during Q1 2019, and its lowest value of $57000.0 during Q3 2017.
  • Over the past 5 years, Larimar Therapeutics' median Other Non-Current Assets value was $90000.0 (recorded in 2016), while the average stood at $488421.1.
  • In the last 5 years, Larimar Therapeutics' Other Non-Current Assets tumbled by 3510.64% in 2016 and then surged by 224912.28% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Other Non-Current Assets (Quarter) stood at $61000.0 in 2016, then dropped by 6.56% to $57000.0 in 2017, then changed by 0.0% to $57000.0 in 2018, then skyrocketed by 57.89% to $90000.0 in 2019, then soared by 1387.78% to $1.3 million in 2020.
  • Its last three reported values are $1.3 million in Q3 2020, $1.3 million for Q2 2020, and $1.3 million during Q1 2020.